COVID-19 Vaccines

DBCAT005462Therapeutic categoryJ07BN

Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. A DrugBank category of 19 drugs. 16 of them are approved.

ATC classification: J — ANTIINFECTIVES FOR SYSTEMIC USE
J07 — VACCINES
J07B — VIRAL VACCINES
J07BN — Covid-19 vaccines
Part of: Viral Vaccines
Also known as: Vaccines for COVID-19
Drugs: Abdavomeran
Andusomeran
AstraZeneca COVID-19 Vaccine
BNT-162A1
BNT162B2 Omicron (LP.8.1)
Davesomeran
Elasomeran
Famtozinameran
Imelasomeran
Janssen COVID-19 Vaccine
mRNA-1283
Nuvaxovid
Pidacmeran
Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccine
Raxtozinameran
Riltozinameran
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains)
Tozinameran
VidPrevtyn Beta

What you can answer from here — as of May 24, 2021

19DrugsEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

73Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do COVID-19 Vaccines share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account